Steve H. Marshall

Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study

Minggui Wang, Michelle Earley, Liang Chen et al. · The Lancet Infectious Diseases · 2021 · 339 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Gene Dosage and Linezolid Resistance in <i>Enterococcus faecium</i> and <i>Enterococcus faecalis</i>

Steve H. Marshall, Curtis J. Donskey, Rebecca Hutton‐Thomas et al. · Antimicrobial Agents and Chemotherapy · 2002 · 266 citations · Full text

Life Sciences, Genetics, Microbiology +17

Colistin Resistance in Carbapenem-Resistant <i>Klebsiella pneumoniae:</i> Laboratory Detection and Impact on Mortality

Laura J. Rojas, Madiha Salim, Eric Cober et al. · Clinical Infectious Diseases · 2016 · 194 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Increasing prevalence and dissemination of NDM-1 metallo- -lactamase in India: data from the SMART study (2009)

Christine Lascols, Meredith Hackel, Steve H. Marshall et al. · Journal of Antimicrobial Chemotherapy · 2011 · 165 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Targeting Multidrug-Resistant <i>Acinetobacter</i> spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent

Melissa D. Barnes, Vijay Kumar, Christopher R. Bethel et al. · mBio · 2019 · 117 citations · Full text

Life Sciences, Microbiology, Pharmacology +17